Plasmacytoid dendritic cell expansion defines a distinct subset of <i>RUNX1</i> -mutated acute myeloid leukemia
Wenbin Xiao(Memorial Sloan Kettering Cancer Center), Ross L. Levine(Memorial Sloan Kettering Cancer Center), Qi Gao(Memorial Sloan Kettering Cancer Center), Sophia Yanis, Ahmet Doǧan(Memorial Sloan Kettering Cancer Center), Nicole L. DelGaudio(Cancer Services), Michael R. Waarts(Cancer Services), Robert L. Bowman(University of Pennsylvania), Jeeyeon Baik, Maria E. Arcila(Memorial Sloan Kettering Cancer Center), Aaron D. Goldberg(Memorial Sloan Kettering Cancer Center), Richard P. Koche(Massachusetts General Hospital), Tanmay Mishra(Vellore Institute of Technology University), Alexander Chan(Memorial Sloan Kettering Cancer Center), Christopher Famulare(Memorial Sloan Kettering Cancer Center), Isabelle Csete(Cancer Services), Raajit K. Rampal(Memorial Sloan Kettering Cancer Center), Mikhail Roshal(Memorial Sloan Kettering Cancer Center), Andriy Derkach(Memorial Sloan Kettering Cancer Center), JinJuan Yao(Memorial Sloan Kettering Cancer Center), Sheng F. Cai(Memorial Sloan Kettering Cancer Center), Ying Liu, Minal Patel(Memorial Sloan Kettering Cancer Center), Martin S. Tallman(Memorial Sloan Kettering Cancer Center), Yanming Zhang(Memorial Sloan Kettering Cancer Center), Maximilian Stahl(Harvard University)
Cited by 119
Related Papers
Diagnosis and management of AML in adults: 2017 ELN recommendations from an international expert panel
|Blood|2016|5.9k
The landscape of somatic copy-number alteration across human cancers
|Nature|2010|4.1k